
|Articles|March 31, 2014
ICON to Acquire Aptiv Solutions
ICON announced its intention to acquire Aptiv Solutions
Advertisement
ICON announced its intention to acquire Aptiv Solutions, a Reston, Va.-based services organization with operations in 16 countries. According to a press release, ICON views Aptiv's strengths in the design and execution of adaptive clinical trials through its ADDPLAN software a strength for its clients. Aptiv also owns a full-service, oncology-focused CRO in Japan, which will be combined with ICON's current operations in Tokyo and Osaka.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
2
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
3
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
4
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
5



